Connect Biopharma Holdings Limited CNTB
0.64 USD -0.03 (-5.05%)
Regular-session close
0.60 -0.04 -6.53%
Pre-market · Nov 17, 4:48 AM ET
0.6001 Day range 0.6677
0.6001 52-week range 3.82
- YTD
- -77.20%
- 1 year
- -69.67%
News
benzinga.com Connect Biopharma Hldgs Q3 EPS $(0.26) Beats $(0.27) Estimate, Sales $736.000K Miss $771.429K Estimate Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.27) by 3.7 percent. This is a 16.13 percent increase over losses…
globenewswire.com Connect Biopharma Reports Third Quarter 2026 Financial Results and Provides Business Update – Reported positive preliminary topline data from global Phase 2 Seabreeze STAT studies evaluating rademikibart as an adjunct treatment for acute exacerbations of asthma and chronic obstructive…benzinga.com HC Wainwright & Co. Reiterates Buy on Connect Biopharma Hldgs, Maintains $7 Price Target HC Wainwright & Co. analyst Brandon Folkes reiterates Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and maintains $7 price target.
